D. Burcoveanu

Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An updated analysis

BackgroundNeurotrophic tyrosine receptor kinase ( NTRK ) gene fusions are oncogenic drivers in various tumour types. Larotrectinib is a first-in-class, highly selective, central nervous s...

T. Andre ;

D. Hong ;

J. Deeken ;

A. Italiano ;

T. Liu ;

D. Burcoveanu ;

R. Norenberg ;

C. Mussi ;

R. Xu ;

A. Drilon ;

Liang Shen , PhD;

06/25/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

D. Burcoveanu

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products